Osteocyte deficiency in hip fractures

Jesús Delgado-Calle, Jana Arozamena, Raúl García-Renedo, Carmen García-Ibarbia, María A. Pascual-Carra, Jesús González-Macías, José A. Riancho

Research output: Contribution to journalArticle

28 Scopus citations


Osteocytes play a central role in the regulation of bone remodeling. The aim of this study was to explore osteocyte function, and particularly the expression of SOST, a Wnt inhibitor, in patients with hip fractures. Serum sclerostin levels were measured by ELISA. The expression of several osteocytic genes was studied by quantitative PCR in trabecular samples of the femoral head of patients with hip fractures, hip osteoarthritis and control subjects. The presence of sclerostin protein and activated caspase 3 was revealed by immunostaining. There were no significant differences in serum sclerostin between the three groups. Patients with fractures have fewer lacunae occupied by osteocytes (60 ± 5% vs. 64 ± 6% in control subjects, P = 0.014) and higher numbers of osteocytes expressing activated caspase 3, a marker of apoptosis. The proportion of sclerostin-positive lacunae was lower in patients with fractures than in control subjects (34 ± 11% vs. 69 ± 10%, P = 2 × 10 -8). The proportion of sclerostinpositive osteocytes was also lower in patients. RNA transcripts of SOST, FGF23 and PHEX were also less abundant in fractures than in control bones (P = 0.002, 5 × 10 -6, and 0.04, respectively). On the contrary, in patients with osteoarthritis, there was a decreased expression of SOST and FGF23, without differences in PHEX transcripts or osteocyte numbers. Osteocyte activity is altered in patients with hip fractures, with increased osteocyte apoptosis and reduced osteocyte numbers, as well as decreased transcription of osteocytic genes. Therefore, these results suggest that an osteocyte deficiency may play a role in the propensity to hip fractures.

Original languageEnglish (US)
Pages (from-to)327-334
Number of pages8
JournalCalcified Tissue International
Issue number4
StatePublished - Oct 1 2011
Externally publishedYes


  • FGF23
  • Osteocytes
  • Osteoporosis
  • PHEX
  • Sclerostin

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Orthopedics and Sports Medicine
  • Endocrinology

Fingerprint Dive into the research topics of 'Osteocyte deficiency in hip fractures'. Together they form a unique fingerprint.

  • Cite this

    Delgado-Calle, J., Arozamena, J., García-Renedo, R., García-Ibarbia, C., Pascual-Carra, M. A., González-Macías, J., & Riancho, J. A. (2011). Osteocyte deficiency in hip fractures. Calcified Tissue International, 89(4), 327-334. https://doi.org/10.1007/s00223-011-9522-0